WHO Drug Information - Volume 37, No. 2

Overview

The second issue of Volume 37, includes

  • Pharmaceutical News: Protection of INN – Ensuring Patients’ Safety and Intellectual Property
  • Consultation Documents: WHO Good Manufacturing Practices for Excipients Used in Pharmaceutical Products
  • ATC/DDD Classification: ATC/DDD Classification (Temporary) and (Final)
  • The WHO Drug Information, Volume 37, N° 2 of 2023, will also include the Proposed International Nonproprietary Names (INN) List N° 129


    International Nonproprietary Names List:

    Issue 2 includes List N° 129 of Proposed International Nonproprietary Names (INN) for Pharmaceutical Substances. This proposed list contains:

    • p.INN list 129 from p. 317 to 515 (deadline for objecting and commenting is 3 December 2023)
    • p.INN list 129 – COVID-19 (special edition - ADDENDUM ) p. 523 to 534 (deadline for objecting and commenting is 3 December 2023)
    • p.INN list 129 – COVID-19 (special edition) p. 516 to 522 (This part has already been published, deadline for objecting and commenting was 14 July 2023)

    WHO Team
    Access to Medicines and Health Products (MHP), INN and Classification of Medical Products (INN), Prequalification (PQT), Regulation and Prequalification (RPQ), Regulation and safety (REG)
    Editors
    World Health Organization
    Number of pages
    313
    Reference numbers
    ISBN: 978-92-4-007623-5
    Copyright